--- title: "Rundu Pharma: Hydrochlorothiazide receives approval for chemical raw material drug listing application" type: "News" locale: "en" url: "https://longbridge.com/en/news/253598914.md" description: "According to the Zhitong Finance APP, Rundu Pharma announced that the company recently received the \"Approval Notice for the Market Application of Chemical Raw Materials\" issued by the National Medical Products Administration for hydrochlorothiazide. This product is suitable for edema diseases, hypertension, central or renal diabetes insipidus, and nephrolithiasis" datetime: "2025-08-19T09:20:02.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/253598914.md) - [en](https://longbridge.com/en/news/253598914.md) - [zh-HK](https://longbridge.com/zh-HK/news/253598914.md) --- # Rundu Pharma: Hydrochlorothiazide receives approval for chemical raw material drug listing application According to the Zhitong Finance APP, Rundu Pharma (002923.SZ) announced that the company recently received the approval notice for the marketing application of hydrochlorothiazide issued by the National Medical Products Administration. This product is suitable for edema diseases, hypertension, central or renal diabetes insipidus, and nephrolithiasis ### Related Stocks - [002923.CN](https://longbridge.com/en/quote/002923.CN.md) ## Related News & Research - [AI|China’s Ganfeng secures orders amid surge in demand for energy storage, AI boom](https://longbridge.com/en/news/286895092.md) - [Motiva Port Arthur refinery reports crude oil release after pipe issues](https://longbridge.com/en/news/286971029.md) - [Bird Construction (TSX:BDT) Is Up 9.1% After Bell AI Data Centre Win And Earnings Beat - What's Changed](https://longbridge.com/en/news/286674765.md) - [PTA-DD: Warimpex Finanz- und Beteiligungs AG: Managers' transactions announcement according to article 19 MAR](https://longbridge.com/en/news/286901864.md) - [12:30 ETInventHelp Inventor Develops New Toilet Bowl Cleaning Tool (TLS-1069)](https://longbridge.com/en/news/286945238.md)